These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 20026964

  • 1. Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy: the usefulness of F-18 FDG PET/CT.
    Kaneko K, Abe K, Baba S, Isoda T, Yabuuchi H, Sasaki M, Hatakenaka M, Honda H.
    Clin Nucl Med; 2010 Jan; 35(1):6-11. PubMed ID: 20026964
    [Abstract] [Full Text] [Related]

  • 2. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 3. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A, Binse I, Grafe H, Ezziddin S, Görges R, Poeppel TD, Bockisch A, Rosenbaum-Krumme SJ.
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [Abstract] [Full Text] [Related]

  • 4. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH, Jung DW, Pak KJ, Kim IJ, Kim HJ, Cho JK, Shin SC, Wang SG, Lee BJ.
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [Abstract] [Full Text] [Related]

  • 5. Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
    Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA.
    Head Neck; 2012 May; 34(5):626-31. PubMed ID: 21850699
    [Abstract] [Full Text] [Related]

  • 6. [Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
    Sun YG, Feng HJ, Liu JH, Hu R, Ouyang W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1571-4. PubMed ID: 21945769
    [Abstract] [Full Text] [Related]

  • 7. Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
    Jung JH, Kim CY, Son SH, Kim DH, Jeong SY, Lee SW, Lee J, Ahn BC.
    PLoS One; 2015 Sep; 10(12):e0144152. PubMed ID: 26636824
    [Abstract] [Full Text] [Related]

  • 8. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [Abstract] [Full Text] [Related]

  • 9. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ, Wu HS, Yen RF, Shen YY, Kao CH.
    Anticancer Res; 2003 Jun; 23(3C):2973-6. PubMed ID: 12926147
    [Abstract] [Full Text] [Related]

  • 10. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
    Kim WG, Ryu JS, Kim EY, Lee JH, Baek JH, Yoon JH, Hong SJ, Kim ES, Kim TY, Kim WB, Shong YK.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1169-73. PubMed ID: 20080852
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT.
    Kaneko K, Abe K, Baba S, Tanabe Y, Yabuuchi H, Hatakenaka M, Sasaki M, Honda H.
    Eur Radiol; 2010 Feb; 20(2):477-83. PubMed ID: 19727757
    [Abstract] [Full Text] [Related]

  • 19. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
    Ong SC, Ng DC, Sundram FX.
    Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
    [Abstract] [Full Text] [Related]

  • 20. Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
    Rosario PW, Mourão GF, dos Santos JB, Calsolari MR.
    Thyroid; 2014 Mar; 24(3):533-6. PubMed ID: 24067080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.